Yukiko Fukuda

Jichi Medical University

Papers

1

Total Citations

2

H-Index

1

About

Dr. Yukiko Fukuda is a leading urologic oncologist whose research focuses on improving outcomes for prostate cancer patients, particularly through the identification of predictive factors for PSA recurrence. Her most impactful work centers on the role of cribriform pattern histology in prostate cancer, demonstrating that this specific architectural feature is a significant predictor of biochemical recurrence in patients receiving salvage radiotherapy after prostatectomy. This finding has critical implications for risk stratification and treatment planning, helping clinicians identify which patients are most likely to benefit from adjuvant therapies. While her 2024 study on this topic has already garnered attention with 2 citations, Dr. Fukuda's broader contributions include advancing the understanding of post-surgical recurrence patterns and refining radiotherapy protocols. Her work bridges the gap between pathology and radiation oncology, offering practical tools for personalized patient management. By highlighting cribriform pattern as a key prognostic marker, Dr. Fukuda has provided the urologic community with a valuable metric for predicting treatment failure, ultimately guiding more effective surveillance and intervention strategies for men with prostate cancer.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Cribriform Pattern Is a Predictive Factor of PSA Recurrence in Patients Receiving Radiotherapy After Prostatectomy
2 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 16
🏛 Institutions: Jichi Medical University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago